AmBisome Monotherapy and Combination AmBisome–Miltefosine Therapy for the Treatment of Visceral Leishmaniasis in Patients Coinfected With Human Immunodeficiency Virus in India: A Randomized Open-Label, Parallel-Arm, Phase 3 Trial( )

BACKGROUND: Visceral leishmaniasis (VL) in patients with human immunodeficiency virus (HIV) presents an increasingly important patient cohort in areas where both infections are endemic. Evidence for treatment is sparce, with no high-quality studies from the Indian subcontinent. METHODS: This is a ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Burza, Sakib, Mahajan, Raman, Kazmi, Shahwar, Alexander, Neal, Kumar, Deepak, Kumar, Vikash, Lasry, Estrella, Harshana, Amit, de Lima Pereira, Alan, Das, Pradeep, Verma, Neena, Das, Vidya Nand Ravi, Lal, Chandra Shekhar, Rewari, Bharat, Goyal, Vishal, Rijal, Suman, Alves, Fabiana, Gill, Naresh, Pandey, Krishna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555838/
https://www.ncbi.nlm.nih.gov/pubmed/35147680
http://dx.doi.org/10.1093/cid/ciac127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555838/
https://www.ncbi.nlm.nih.gov/pubmed/35147680
http://dx.doi.org/10.1093/cid/ciac127

Ejemplares similares